– Russia said it test-patients for the vaccine were set to be discharged soon
– This particular vaccine was reportedly developed by Oxford University and was also being tested by other countries
– The trial, according to researchers, showed promise and proved the vaccine was safe and effective
Brazil might have been the first country to test the COVID-19 vaccine developed by Oxford University, but it appears Russia has made it to the finish line first.
The nation said it had successfully completed human trials of the vaccine, with Elena Smolyarchuk from the Russian Center for Clinical Research on Medications at Sechenow University, saying that test-patients were set to be discharged soon.
Forbes reported there was no indication of when the vaccine would enter commercial production; nevertheless, this was the ray of hope the world needed in the fight against the virus.
“The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20,” she said.
Professor Zeblon Vilakazi who facilitated the virtual launch weighed in on the historic moment by saying a vaccine would go a long way in saving lives.
Do you have a groundbreaking story you would like us to publish? Please reach us through [email protected] or WhatsApp: 0732482690. Contact Tuko.co.ke instantly.
A father turned his 8-year-old girl into his wife, then a stranger rescued her | Tuko Talks| Tuko TV